Navigation Links
NBTY To Web Cast Presentation at CL King Best Ideas Conference; Announces Preliminary Unaudited Net Sales Results For August 2009
Date:9/10/2009

RONKONKOMA, N.Y. Sept. 10 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that it will web cast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the CL King Best Ideas Conference in New York on Thursday, September 17, 2009.

The presentation is scheduled to be web cast live on NBTY's web site, (www.nbty.com) on Thursday, September 17, 2009 at 2:15PM Eastern Time.

NBTY's preliminary unaudited net sales results for August 2009 by segment are as follows:

                                       NET SALES
                              (Preliminary and Unaudited)
                                FOR THE MONTH OF AUGUST
                                     ($In Millions)

                                                 2009        2008     % Change
                                                 ----        ----     --------

    Wholesale / US Nutrition                     $148        $124          19%

    North American Retail                         $18         $17           2%

    European Retail                               $53         $44          20%

    Direct Response / E-Commerce                  $18         $18          -3%
                                                  ---         ---          ---

    Total                                        $236        $204          16%
                                                 ====        ====          ===

Leiner Health Products, which was acquired on July 14, 2008, has been fully integrated into the Wholesale / US Nutrition operations. North American Retail same store sales increased 2% for the one month period. European Retail net sales for August 2009 include $9 million from Julian Graves, which NBTY acquired on September 16, 2008. Without Julian Graves sales, European Retail net sales decreased 1%. In local currency (British Pound Sterling), excluding Julian Graves sales, European Retail net sales increased 14%.

NBTY's preliminary unaudited net sales results for the two months of July and August 2009 by segment are as follows:

                                       NET SALES
                             (Preliminary and Unaudited)
                          FOR THE TWO MONTHS JULY AND AUGUST
                                    ($In Millions)

                                                 2009        2008     % Change
                                                 ----        ----     --------

    Wholesale / US Nutrition                     $275        $230          20%

    North American Retail                         $34         $34           0%

    European Retail                              $108         $91          19%

    Direct Response / E-Commerce                  $37         $37          -1%
                                                  ---         ---          --

    Total                                        $454        $391          16%
                                                 ====        ====          ===

As previously stated, Leiner Health Products, which was acquired on July 14, 2008, has been fully integrated into the Wholesale / US Nutrition operations. North American Retail same store sales decreased 1% for the two-month period of July and August 2009. European Retail net sales for

the two-month period of July and August 2009 include $18 million from Julian Graves, which NBTY acquired on September 16, 2008. Without Julian Graves sales, European Retail net sales decreased 1%. In local currency (British Pound Sterling), excluding Julian Graves sales, European Retail net sales increased 16%.

ABOUT NBTY

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R) (www.NaturesBounty.com), Vitamin World(R) www.VitaminWorld.com), Puritan's Pride(R) (www.Puritan.com), Holland & Barrett(R) (www.HollandAndBarrett.com), Rexall(R) (www.Rexall.com), Sundown(R) (www.SundownNutrition.com), MET-Rx(R) (www.MetRX.com), Worldwide Sport Nutrition(R) (www.SportNutrition.com), American Health(R) (www.AmericanHealthUS.com), GNC (UK)(R) (www.GNC.co.uk), DeTuinen(R) (www.DeTuinen.nl), LeNaturiste(TM) (www.LeNaturiste.com), SISU(R) (www.SISU.com), Solgar(R) (www.Solgar.com), Good 'n' Natural(R) (www.goodnnatural.com), Home Health(TM) (www.homehealthus.com), Julian Graves, and Ester-C(R) (www.Ester-C.com) brands. NBTY routinely posts information that may be important to investors on its web site.

    Contact: Harvey Kamil                           Carl Hymans
             NBTY, Inc.                             G.S. Schwartz & Co.
             President & Chief Financial Officer    212-725-4500
             631-200-2020                           carlh@schwartz.com

'/>"/>
SOURCE NBTY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Echo Therapeutics Announces New Presentation Time at Rodman & Renshaw 2009 Annual Global Investment Conference
2. Cell Therapeutics, Inc.s (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
3. Haemacure announces its presentation at the Rodman Renshaw 11th Annual Healthcare Conference
4. Volcano Corporation Presentation at Weisel Conference to be Webcast
5. Hospira Receives FDA Approval for Six New Presentations of Heparin
6. Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
7. The Cosmetic Bootcamp LLC Announces Novel Presentations at Its 3rd Annual Marketing and Management Symposium
8. ColorAlchemy Presentation at 5th Largest Unity Church Reveals How Yellow Commands Greater Personal Power
9. Cepheid to Webcast Upcoming Financial Presentations
10. PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard(R) at ESC 2009 Has Been Published; Strong Preliminary Results Seen
11. NBTY to Web Cast Presentation at Canaccord Adams Global Growth Conference; Announces Preliminary Unaudited Net Sales Results for July 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... California (PRWEB) , ... August 16, 2017 , ... An August 3rd article ... was the subject of a report in JAMA (the Journal of the American Medical Association). ... 50 were able to achieve BMIs under 30, when compared to patients with lower BMIs. ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data ... today that it was acquired by Advantage Solutions. The Data Council’s IX-ONE ... members include the industry’s leading suppliers, brokers, distributors and retailers. The Data Council ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... opened their doors. They celebrate 30 years in business this year, and they’re ... up-to-date, inviting, tranquil space to serve their patients. , It stands to ...
(Date:8/16/2017)... KS (PRWEB) , ... August 16, 2017 , ... ... latest beneficiary of their recently launched community enrichment program. Partnering once again with ... the KC Superstar competition to help find the area’s very own American Idol. ...
(Date:8/16/2017)... TX (PRWEB) , ... August 16, 2017 , ... ... as a Castle Connolly 2017 Top Doctor. The annual list identifies the nation’s top ... that Dr. Vitenas has made it to the top of Castle Connolly’s coveted ranking. ...
Breaking Medicine News(10 mins):
(Date:8/11/2017)... Israel , Aug. 11, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... on Monday, August 14 and host a conference call ... quarter 2017 operating and financial results and its strategy ... will be hosted by Erez Raphael , Chief ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... 7, 2017 Insightin Health, provider of ... and engagement, announced the selection of Michael ... Development, effective as of February 2017. In this role, ... strategy for our clients. Wood brings with him ... and business analytics within the healthcare industry. Wood ...
Breaking Medicine Technology: